A physician-supervised GLP-1 program — semaglutide, tirzepatide or retatrutide — begun in the calm of your Tulum villa and carried home through licensed telehealth. Your clinician screens you first; not everyone is a candidate.
GLP-1 medicines are a class of injectable peptides that act on the body’s own appetite and metabolic signalling — the same pathways that govern hunger, fullness and how the body handles food. This program offers three, in order of strength. Semaglutide is the molecule behind Ozempic and Wegovy; tirzepatide (Mounjaro / Zepbound) adds a second signal, GIP; and retatrutide is the newest, a triple agonist acting on GLP-1, GIP and glucagon at once.
Honesty matters here, so a plain word on status. The branded semaglutide and tirzepatide products are FDA-approved with large randomised human trials behind them. Retatrutide is investigational — it is in late-stage Phase 3 study and is not yet FDA-approved, so it is offered only in a wellness & research context under a physician. Where a program uses compounded rather than branded medication, that too sits outside the FDA-approved branded channel — your clinician will explain exactly what you are being prescribed.
What every version shares: it is a supervised medical program, not a purchase. A physician screens you, decides whether it suits you, and titrates the dose gradually.
For the first time, metabolic health is being understood not as a matter of willpower but as biology we can support with care and science. GLP-1 medicines have opened a wider, more compassionate conversation about weight and feeling at home in your body.
“It’s a brain disease. And the brain tells us how much to eat and how much to store.”
“I’m absolutely done with the shaming from other people and particularly myself.”
“Ozempic Santa. Technically, Mounjaro, but that doesn’t have the same ring to it.”
Public statements about metabolic health in general, shared as context — not endorsements of Seva Vitality or any treatment.
Guests choose the GLP-1 program for a supervised, structured approach to weight and metabolic goals — started somewhere unhurried and private, then continued at home. It is designed for people who want medical oversight rather than a mail-order vial. It begins with screening, and not everyone is a candidate.
Everything starts with a screen. Before anything is charged, a physician reviews your health history and goals to decide whether a GLP-1 program suits you and, if so, which molecule and starting dose. In your villa, a clinician then reconstitutes your medication with you, teaches you to draw and dose, and supervises your first injection — so you leave genuinely able to run it, not deciphering a forum thread. You go home with a take-home starter kit (vials, supplies, safe sharps disposal), a personalised dosing card in plain language, and a remote follow-up plan.
Because GLP-1 dosing is a titration over months, the program is built to continue. We keep it running through a licensed telehealth partner once you’re home, with re-supply — so progress doesn’t stop when the trip does. Plans come as 30-, 60- or 90-day runs; the longer the plan, the better the monthly rate.
Dr Alex Tatem is a urologist who has worked with peptides for over a decade. He sat down with Steven Bartlett on The Diary of a CEO for 89 minutes. This link opens the exact moment he discusses semaglutide, tirzepatide & retatrutide — so you can form your own view before you speak to anyone here.
Peptide Expert: What Do Peptides Actually Do? (EXPLAINED) — Dr Alex Tatem, with Steven Bartlett.
Watch on YouTube →Independent interview, linked for education. Dr Tatem is not affiliated with SEVA, has no commercial relationship with us, and does not endorse our services or any protocol we offer. Nothing in it is medical advice or a promise of any result — and it is not specific to you. Every protocol here begins with a physician screening.
Reserve in two minutes. Your card is only held — a clinician reviews your details and screens you first; you’re charged only once your protocol is confirmed.
Most clinics hand you a pen and wave goodbye. SEVA does the opposite: a physician screens you first, a clinician teaches you to inject in the privacy of your villa, every vial is third-party lab-verified with a certificate of analysis you can read, and a licensed telehealth partner carries the program home — taught and supervised, not merely sold.
GLP-1 medicines are injectable peptides that act on the body’s natural appetite and metabolic signalling — the pathways governing hunger and fullness. Semaglutide, tirzepatide and retatrutide are all in this family, each acting on a slightly different set of receptors. In this program every one is prescribed and supervised by a physician after screening.
They differ by how many signals they act on. Semaglutide (the Ozempic / Wegovy molecule) targets GLP-1. Tirzepatide (Mounjaro / Zepbound) adds a second, GIP. Retatrutide is a triple agonist acting on GLP-1, GIP and glucagon — the newest and strongest in class, and the one still investigational. Your clinician will talk you through which fits your goals at your screening.
No. As of 2026 retatrutide is investigational — in late-stage Phase 3 trials and not yet FDA-approved. It is offered only in a wellness & research context under physician supervision, after screening. Semaglutide and tirzepatide, by contrast, are FDA-approved branded medicines; where compounded versions are used, your clinician will tell you plainly.
The program is physician-supervised in Mexico and begins with a medical screen — not everyone is a candidate, and that’s the point. GLP-1 medicines carry known side effects (commonly nausea and other digestive effects, with less-common risks your physician reviews with you), which is why dosing is titrated slowly and overseen throughout. It is not a fit for everyone; your clinician decides.
We don’t promise a number — responses vary from person to person, and GLP-1 dosing is deliberately titrated upward over weeks and months rather than rushed. What we can say is that the program is designed to be continued steadily under supervision, which is how these medicines are intended to be used.
Yes — that’s the design. You start in your villa and continue through a licensed telehealth partner once home, with remote follow-up and re-supply. You leave with a starter kit and a dosing card, taught to self-inject, so the program travels with you. See how to begin.
You’re taught, not left guessing. In your villa a clinician reconstitutes the medication with you, shows you how to draw and dose, and supervises your first injection. GLP-1 injections are small and subcutaneous. You go home with a plain-language dosing card and remote support for the questions that come up.
Seva Vitality provides wellness and optimization services in a private, physician-supervised setting. It is not intended to diagnose, treat, cure or prevent any disease; a health screen applies and not all treatments suit everyone. Peptide and GLP-1 therapies described here are physician-led and, where applicable, not FDA-approved and offered in a wellness & research context under medical supervision.